In an article for industry publication WorkCompWire, myMatrixx Chief Clinical Officer, Phil Walls, highlighted the key stories and trends coming out of the release of the 2019 Drug Trend Report. The annual report, released on July 8th, provides an in-depth analysis of pharmaceutical data in the workers’ compensation sector. Through this publication, myMatrixx aims to keep industry professionals and clients informed on important developments driving prescription drug spend and patient safety.
In the WorkCompWire piece, Phil previews the report and shares some of the key figures and findings that the myMatrixx and Express Scripts clinical teams uncovered. Topics discussed include a 6.1% decrease in drug spend, a continuing decline in opioid utilization and the effect of private label topicals on workers’ comp drug claims. You can read the full article here on the WorkCompWire website.